Welcome to our dedicated page for BWX Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on BWX Technologies stock.
BWX Technologies, Inc. (BWXT) is a premier provider of nuclear components and fuel to the U.S. government. The company is renowned for its technical expertise, management, and site services, supporting government operations of complex facilities and environmental remediation activities. BWXT also plays a critical role in the commercial nuclear power industry, offering precision-manufactured components and specialized services.
Headquartered in Lynchburg, Virginia, BWXT has a significant presence with operations in Erwin, Tennessee; Mount Vernon, Indiana; Euclid, Ohio; Barberton, Ohio; Cambridge, Ontario, Canada; and over a dozen U.S. Department of Energy sites around the country. It employs more than 5,200 skilled professionals dedicated to advancing nuclear technology and safety.
BWXT operates in two main segments: Government Operations and Commercial Operations. The Government Operations segment encompasses the legacy Nuclear Operations Group and Nuclear Services Group, focusing on advanced reactor projects and innovative manufacturing techniques. The Commercial Operations segment includes the legacy Nuclear Power Group, which engages in research, development, and commercialization of medical and industrial radioisotopes and radiopharmaceuticals.
The company’s financial health is robust, with a majority of its revenue generated from its Government Operations segment. BWXT’s strategic partnerships and projects aim to enhance its market presence and technological capabilities. Geographically, while the company operates in the United States, Canada, and the United Kingdom, the bulk of its revenue comes from the United States.
Recent achievements highlight BWXT's commitment to innovation and excellence. The company continues to secure significant contracts, invest in cutting-edge technologies, and expand its services in the nuclear sector. These efforts underscore BWXT’s pivotal role in both government and commercial nuclear projects.
BWX Technologies, Inc. (NYSE: BWXT) announced $35 million in contracts awarded to its subsidiary, BWXT Nuclear Operations Group, for uranium recovery and conversion and research reactor fuel line construction. The U.S. Naval Nuclear Propulsion Program awarded a $17.4 million contract for uranium recovery, while the U.S. Department of Energy’s NNSA awarded $17.9 million for a HALEU fuel project. These projects leverage BWXT's expertise in nuclear fuel processing and support global security by promoting nonproliferation.
BWXT Medical and Global Medical Solutions have formed a joint venture (JV) to create a reliable supply of radioisotopes and radiopharmaceuticals in the Asia-Pacific region. BWXT Medical plans to replicate its North American operations in Asia, focusing on technetium-99m (Tc-99m) generators, which are crucial for over 40 million diagnostic imaging procedures worldwide annually. The JV aims to alleviate Asia's reliance on European and U.S. supplies, enhancing service reliability. Initial investment is expected to begin in 2023, with both companies optimistic about meeting rising demand.
BWX Technologies, Inc. (NYSE: BWXT) announced a $57.5 million contract awarded to its subsidiary Nuclear Fuel Services, Inc. (NFS) by the National Nuclear Security Administration (NNSA). This contract focuses on developing highly enriched uranium (HEU) conversion and purification services. NFS will design a process for converting oxide to purified HEU metal, providing a critical bridging capability while the Y-12 National Security Complex modernizes its operations. Work will commence immediately under this firm-fixed price agreement.
BWX Technologies, Inc. (NYSE: BWXT) has announced that CFO David Black will present at the virtual J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference on March 1, 2021. As a leading supplier of nuclear components and services, BWXT is the exclusive manufacturer of U.S. naval nuclear reactors for submarines and aircraft carriers. The presentation will be accessible in the Investor Relations section on their website but will not be available as a webcast.
BWXT, headquartered in Lynchburg, VA, employs approximately 6,700 individuals across 12 major sites in the U.S. and Canada.
BWX Technologies reported record Q4 2020 revenue of $557 million, an 11% increase from Q4 2019. GAAP net income rose to $65.7 million ($0.69/share) versus $61.4 million ($0.64/share) last year. Full-year revenue also set a record at over $2.1 billion, up 12% from 2019. Despite pandemic challenges, the company anticipates modest growth in 2021, with guidance for non-GAAP EPS between $3.05 and $3.20. The company plans to return $94.9 million to shareholders in 2020 and declared a dividend of $0.21 per share.
BWX Technologies, Inc. has renamed its subsidiary, previously known as BWXT ITG Canada, Inc., to BWXT Medical Ltd. This change better aligns with its focus on nuclear medicine, particularly the production of molybdenum-99 and technetium-99m generators, crucial for over 40 million annual diagnostic imaging procedures. The company aims to strengthen its position in the nuclear medicine sector, led by Martyn Coombs. BWXT Medical is part of the broader Nuclear Power Group, and the company emphasizes its ongoing progress and strategic partnerships in this area.
BWX Technologies, Inc. (BWXT) will hold a webcast to discuss its fourth quarter 2020 results on February 23, 2021, at 9:00 a.m. EST. The results will be released after the market closes on February 22. Participants can join by phone or view the presentation online at www.bwxt.com/investors. The U.S. dial-in number is 844-850-0542 and 412-317-6014 for international callers. A replay will be available on the BWXT website.
BWX Technologies, Inc. (NYSE: BWXT) has appointed Dr. Robert (Rob) F. Smith as president of government operations. Reporting to CEO Rex Geveden, Smith will oversee BWXT's nuclear business lines, including projects for the Naval Nuclear Propulsion Program and other government agencies. Smith brings extensive experience from Lockheed Martin and the NSA, holding a doctorate in chemical engineering and an MBA. He will start at BWXT's Lynchburg, Va. headquarters in January 2021, contributing to the company's growth and operational performance.
BWX Technologies, Inc. (NYSE: BWXT) has been awarded a $106.6 million microreactor development project by the U.S. Department of Energy (DOE), which will contribute $85.3 million over seven years. The project aims to develop a transportable microreactor using advanced TRISO fuel particles to enhance uranium loading and fuel efficiency. BWXT will collaborate with the Idaho National Laboratory and Oak Ridge National Laboratory. This initiative is part of the DOE's Advanced Reactor Demonstration Program, which plans to invest $600 million over seven years.
BWX Technologies, Inc. (NYSE: BWXT) has appointed retired Adm. John M. Richardson to its board of directors. Adm. Richardson, former Chief of Naval Operations, brings extensive operational and national security experience, managing a $160 billion budget and overseeing 600,000 personnel. His background includes key roles in naval nuclear propulsion, providing him with insights beneficial to BWXT’s mission in nuclear solutions for various sectors. The chairman of BWXT commended his national security expertise and executive skills as assets to the company.
FAQ
What is the current stock price of BWX Technologies (BWXT)?
What is the market cap of BWX Technologies (BWXT)?
What does BWX Technologies, Inc. (BWXT) specialize in?
Where is BWXT headquartered?
How many employees does BWXT have?
What are the main segments BWXT operates in?
Which segment contributes the most to BWXT's revenue?
Where does BWXT have significant operations?
What are BWXT's recent achievements?
What industries does BWXT serve?
Does BWXT operate internationally?
What kind of services does BWXT provide?
